Conflict of interest summary

From Cancer Guidelines Wiki

Conflict of interest summary


Professor Villis Marshall AC -- Chair
Urologist in Clinical Practice
Clinical Director of Surgical and Specialties Service, Royal Adelaide Hospital
Significant input into Guideline development and translating these to community friendly document
Abbott Advisory Board on LUCRIN.


Mr Don Baumber
Consumer
Currently undergoing treatment in Holland


Associate Professor Damien Bolton FRACS
Urologist. Associate Professor, Austin Hospital, Heidelberg
Sponsored to attend a conference by Ipsen Pharmaceuticals and also by Abbott Australasia


Dr Mary Brooksbank AM MB, BS; FRACS; FAChPM'
Director of Palliative Care, Royal Adelaide Hospital and Medical Director, Mary Potter Hospice, Calvary Healthcare, North Adelaide
Senior Lecturer, Discipline of Medicine, University of Adelaide
No conflict of interest to declare in relation to these Guidelines


Professor Suzanne Chambers
Director of Research and General Manager Services
Cancer Council Queensland
No conflict of interest to declare


Ms Helen Crowe
Urology Nurse Practitioner/Urology Research Nurse
Royal Melbourne Hospital
No conflict of interest to declare


Professor RA 'Frank' Gardiner AM
University of Queensland Centre for Clinical Research
Consultant Urologist, Royal Brisbane and Women’s Hospital
Member of the Denosumab Advisory Board for Amgen in 2007, member of the Satrplatin Advisory Board for Pharmion in 2006, member of Pfizer’s International Steering Committee for Darafenacin (2000–2002), member of Natbio’s Medical and Biological Advisory Committee (2003–2007), member of Advisory Board for Roche Products regarding Fleroxacin (QuinodisTN) in 1992.

Not presently a member of any industry boards and none of the above relate to androgen deprivation therapies. (Satraplatin is a cytotoxic drug and Denosumab is a human monoclonal antibody to Rank ligand to prevent bone metastases in prostate and other cancers. Darafenacin is an anticholinergic drug used for treatment of urinary incontinence and Fleroxacin is/was an antibiotic.

Member of a group undertaking commissioned clinical trials for industry for which payment is received and used to bolster finances for research activities. About to commence a trial with abiraterone (which blocks androgen production from the adrenal) in patients with castrate-resistance prostate cancer and a study using an infrared light to destroy BPH tissue in patients primed with a porphyrin to enhance the activity of the infrared light. Hoping to undertake a further study with Amgen imminently with Denosumab in patients with castrate resistant prostate cancer. Presently doing a study with Botox for urinary incontinence and hope to participate in an extension study.


Dr Kumar Gogna
Senior Radiation Oncologist
Mater Radiation Oncology Unit, Brisban
No conflict of interest to declare


Ms Hayley Griffin
Nutrition Project Officer
Cancer Council NSW
Received a four year scholarship from MINTRAC (National Meat Industry Training AdvisoryCouncil Limited) towards PhD to conduct an RCT on higher protein diets for weight loss in young, overweight and obese women (The WOW Study).


Associate Professor Howard Gurney
Medical Oncology
Westmead Hospital
Sponsorship to attend scientific meeting – Pfizer. Advisory Boards Pfizer, Wyeth, Novartis. Research Support.


Professor David Handelsman
Inaugural Professor/Director for ANZAC Research Unit. Head of Andrology Laboratory
Repatriation Hospital, Concord, NSW
Response awaited.


Ms Suzanne Hughes
Project Officer
Cancer Epidemiology Unit
Cancer Council NSW
No conflict of interest to declare


Mr Trevor Hunt
Consumer – deceased


Dr Andrew Kneebone
Senior Staff Specialist in radiation oncology
Royal North Shore Hospital
No conflict of interest to declare


Associate Professor Jeremy Millar Radiation Oncologist
Director, William Buckland Radiotherapy Centre, Alfred Hospital, Melbourne
No conflict of interest to declare


Ms Jill Margo AM
Medical Journalist
Columnist “Men’s Health”
Australian Financial Review
No conflict of interest to declare


Professor Diane O’Connell
Cancer Epidemiology Research Unit
Cancer Research Unit, Cancer Council NSW
Andrology Australia and Prostate Cancer Foundation of Australia provided funding to the Cancer Council NSW to conduct the systematic reviews. However neither organisation had any input into the methods used or the reporting of the information. Subsequently received a grant from PCFA to examine the use of complementary and alternative therapies by men with prostate cancer which arose from the systematic reviews completed for the guidelines.


Dr Carole Pinnock
Principle Research Scientist
Urology Unit, Repatriation General Hospital, Daw Park, South Australia
No conflict of interest to declare.


Emeritus Professor Tom Reeve AC CBE Senior Medical Advisor, Australian Cancer Network
No conflict of interest to declare.


Professor Mark Rosenthal
Director of Medical Oncology
Royal Melbourne Hospital
Member of Annual International Sanofi-Aventis Advisory Board for which he receives an Honorarium.


Dr Sabe Sabesan Director of Medical Oncology
Department of Medical Oncology, Townsville Hospital
No conflict of interest to declare


Associate Professor Thomas Shakespeare
Senior Radiation Oncologist
Coffs Harbour Health Campus UNSW
Dr Shakespeare’s unit received an educational/research grant from a pharmaceutical company but he was not a recipient of those funds. No other conflict of interest to declare.


Dr David Smith
Research Fellow in Epidemiology
Cancer Research Unit, Cancer Council NSW
No conflict of interest to declare.


Associate Professor Phillip Stricker
Urologist
St Vincent’s Clinic, Darlinghurst
No conflict of interest to declare


Professor Christopher Sweeney MBBS
Formerly Professor of Medical Oncology, Royal Adelaide Hospital
Associate Physician, Dana-Farber Cancer Institute, Harvard University
While in Adelaide, Professor Sweeney had been sponsored to give talks, be on advisory boards and to attend ASCO by Novartis, AstraZeneca, Sanofi-aventis, Pfizer and Roche.


Dr Agnes Vitry
Senior Research Fellow, University of South Australia
No conflict of interest to declare


Ms Christine Vuletich
Executive Assistant, Australian Cancer Network
No conflict of interest to declare


Dr Kirsty Wiltshire
Radiation Oncologist, William Buckland Radiotherapy Centre, Alfred Hospital, Melbourne
No conflict of interest to declare


Ms Alice Winter-Irving
Office Assistant, Australian Cancer Network
No conflict of interest to declare.


Back to top